Tag: PGNX

Blue Horseshoe Stocks: WATT Recap & More

Energous Corp. WATT

On our premarket watchlists for both Wednesday and yesterday morning, has been WATT, which received some exciting news this week.

The company revealed that the FCC has granted consumer safety certification for its wireless charging technology, marking the first FCC approval for remote wireless charging, and opening the door to commercialization.

Its applications are plentiful, and the potential is high, and it’s showing on the chart. On Wednesday morning following our alert, the stock was trading for as little as 15.30, and at its high of day yesterday, the stock had reached 33.50. That represented a two-session swing of 119% as it set new all-time highs for volume two days in a row.

We will be very interested to continue tracking the story behind this huge turn of events for WATT.

Helios and Matheson Analytics, Inc. HMNY

We also would like to recap HMNY’s performance yesterday. We tagged this one as a bottom play and ended up timing the bounce with absolute precision.

The stock had been in an overall downtrend since the end of November, and yesterday, began what could be just the start of a more sustained recovery.

HMNY traded up from a low of 5.45 and went on to reach a high of 6.98, for a modest but respectable increase of 28% on the day. It happened on roughly three times the monthly average volume, and closed near the high of day, so we’ll definitely be on the lookout for momentum carryover.


INSYS Therapeutics, Inc. INSY

Just a quick reminder about the options idea we had for INSY recently. We already reported the solid gains we’ve witnessed in the INSY 01/19 $8 and $9 Calls on Wednesday morning, but given the current conditions on the chart, we’ll want to keep an eye peeled for further bullish activity in those contracts.

Extended Watchlist:
ADHC, AGTK, CATB, GENE, PGNX, PGLC, SMIT,

Blue Horseshoe Stocks: Kicking Off the Short Week

Netflix Inc. NFLX – Options Update

We hope all of our readers enjoyed the long holiday weekend! Our first order of business this morning is to provide an update on Friday’s options trading idea. We signaled our interest in tracking the NFLX Weekly $93.50-95.50 Calls for potential daytrades, and every one of the contracts within our targeted range allowed for multi-bag single-session gains.

$93.50 Calls – Range: 1.47-3.22 – Max Gain: 119%
$94 Calls – Range: 1.16-2.75 – Max Gain: 137%
$94.50 Calls – Range: .97-2.50 – Max Gain: 158%
$95 Calls – Range: .57-2.00 – Max Gain: 251%
$95.50 Calls – Range: .31-1.53 – Max Gain: 394%

We always issue the same warning when we submit a weekly options idea on a Friday, stating that it is very high-risk. While that is true, the high reward factor like we saw here is what keeps us interested in this sort of options trading.


More Updates

Lot78, Inc. LOTE – This was one of a pair of stocks we tagged for observation in Thursday morning’s premarket report, which finished off the week on a strong note. From a low of .0037, it surged to .0063 toward the end of the session. It closed at that high of day, having made an intraday jump of 70%

We’ll remain interested in LOTE moving forward provided it can maintain support at or above the .0046 level.

______

GreenGro Technologies, Inc. GRNH – This is a stock that we’ve literally mentioned dozens of times in the past. Most recently was on Thursday, at which time we witnessed the stock trading at a nickel. Friday, it managed to reach .07, an overnight increase of 40%

We’ll also leave this on our radars going forward to watch for signs of a continued uptrend.

SAExplorations Holdings, Inc. SAEX

We’re going to be keeping an eye on SAEX, which raised flags on Friday with a hearty 70% bounce off of its 52-week low, established on Thursday.

Whenever we see stocks in this position, we’re interested in the possibility of taking advantage of the volatility and possible recovery. A return to even the current 50DMA of .48, where the stock was trading merely a week ago, would spell double-bag gains from current PPS levels.

Extended Watchlist:
GALE, PGNX, BCRX, FCSC, DRYS, AXU, BIND

Blue Horseshoe Stocks: Fresh Options Ideas & More

Pazoo Inc. PZOO

PZOO has been progressing well in the past several sessions since we last touched base with the stock a couple of weeks ago. We had just received word from the company that its wholly-owned CannabisKing Distribution subsidiary had struck two significant deals (Links to PR’s below), and witnessed a two-session swing of 74% as a result.

After regrouping and bouncing off of a low of .0046 (07/13), PZOO has made continuously higher lows for the rest of this month, and pushed its PPS back to the current range (.006-.007). We’ve provided the following snapshot illustrating the current bullish characteristics of the chart.

We’ll be on the lookout for further updates regarding the many irons PZOO currently has in the fire, and you can be sure that we’ll pass them along as the stories develop.

Fresh Options Ideas

As we approach midweek with earnings drops in full swing, we’re going to formulate a few corresponding options ideas we feel have the potential to perform well:

Ford Motor Co. (F) – Ford set record North American profits and beat Wall St. expectations handily this morning. The stock is gapping up moderately, so we’re going to taking a look at F Weekly $14.50 and $15 Calls, which should produce some nice action.

Pfizer, Inc. PFE –  Pfizer also had an earnings beat on their Q2 release today, and our related options ideas will be to monitor PFE Weekly $34.50 and $35 Calls.

Baidu, Inc. BIDU – After an extreme analyst downgrade, BIDU is taking an absolute beating, and is leading us to include a rare idea on the bearish side of things; we’ll be tracking BIDU Weekly Puts in the $180-175 Range.

Cytori Therapeutics, Inc. CYTX

We also want to raise a flag on a familiar stock cropping up in the news feed this morning. Early this year we saw CYTX make a huge move, and after spending the last several months in a general downtrend, some FDA-related news out this morning could be just the thing to catalyze a reversal. We’ll be watching intently for that possibility; check out the news below.

Cytori Therapeutics, Inc. (CYTX) today announced that Kerastem Technologies, a wholly owned subsidiary of Bimini Technologies, received U.S. Food and Drug Administration (FDA) conditional Investigational Device Exemption (IDE) approval to conduct a clinical trial studying the safety and feasibility of its technology for the treatment of female and early male pattern baldness (androgenic alopecia). >> FULL PR

Extended Watchlist:
PGNX, SDRL, NYMX, AKS, RJET